GTX medical was founded in December 2014, splitting off from the Swiss federal institute of technology Lausanne (EPFL) to specifically develop a new neurostimulation therapy.
We are based at the High-Tech Campus in Eindhoven, Netherlands, and at the Technical and Life Science Faculties of EPFL, Lausanne, Switzerland. Both our sites are locations where world class research is developed, and we are proud to continue in this tradition.
Based on years of research by Professor Grégoire Courtine at EPFL CNP, we have developed an advanced therapy to help people with paraplegia recover the strength and ability to once again use their legs. Using a targeted neuro-stimulation implant with real-time motion feedback, combined with bodyweight support assisting training tools, our technology has the potential to restore the function of the spinal cord and improve the rehabilitation of individuals with SCI. We call this approach Targeted Epidural Spinal Stimulation (TESS). The therapy allows remodeling of neural pathways, repairing the connection between brain, spine, and lower extremities – with the potential of improving other symptoms related to spinal cord injuries.
We are the only company worldwide to develop an implantable neural stimulation system to restore the ability to walk.
At GTX, our team of over 70 people work closely with our academic founders, along with 40 researchers and clinicians, based in both EPFL, and the University Hospital in Lausanne (CHUV).
Our company is led by CEO Sjaak Deckers, an entrepreneur with previous successful experience at Sapiens Steering Brain Stimulation, until its acquisition by Medtronic in 2014. Our Chief Science Officer is Grégoire Courtine, whose research makes the development of our neuro-stimulation implants possible.
EPFL and Courtine’s lab plan to start a new study in the second half of 2019, after the success of the previous study as published in Nature and Nature Neuroscience and to which GTX is associated. Our initial focus is on individuals with paraplegia with an incomplete SCI due to a lesion in the cervical or thoracic segments of the spinal cord. However, we intend in the future to explore helping people with more severe lesions, and other neurological disorders.
Besides our report to the research, we also need to provide a device to administer the stimulation. In tandem with Grégoire Courtine’s research, we are currently developing the Go-2 Targeted Epidural Spinal Stimulation (TESS) system to eventually provide hospitals and people with paraplegia with the focused technology to aid rehabilitation and improve lives. GTX medical is aiming to gain CE certification and FDA approval in the future.
Who We Are
GTX is made up of a growing team of committed experts, passionate about our aim to develop life-changing technology for individuals with SCI. Each of us is an expert in our field: whether that’s engineering, neuroscience, finance, product R&D, developing clinical and regulatory pathways or marketing. We are highly optimistic on the success for TESS, and the Go-2 TESS System. Therefore, we work hard behind the scenes to achieve our goal – to provide a viable and safe product that can go to market and aid in the rehabilitation of people with paraplegia.
Our Board of Directors
14 Jun 2019:
Prof. Grégoire Courtine was celebrated in Washington D.C. as one of the five 2019 Rolex Award laureates. For more than 40 years, the Rolex Awards have supported individuals with projects that advance human knowledge, protect cultural heritage or help preserve natural habitats and species.
5 May 2019:
Wings for Life – World Run 2019: The GTX / STIMO teams put in some fantastic efforts on Sunday May 5th by ‘running for those who can’t’.
The teams were spread over several locations including Nijmegen (NL), Lausanne (CH), Zug (CH) and Gent (BE) with the proudest moments being the participation of the 3 STIMO participants Gert-Jan in Nijmegen, David in Zurich and Mathieu in Lausanne!
Nieuwsbrief Sint Maartenskliniek Apr 2019 (Update in Dutch only):
De Sint-Maartenskliniek, Nijmegen lanceert een nieuwsbrief rondom zenuwstimulatie. Om deze en andere edities van de nieuwsbrief per e-mail te ontvangen, kunt u zich aanmelden via deze pagina: https://www.maartenskliniek.nl/contact-opnemen-inzake-dwarslaesierevalidatie
5 Mar 2019, FranceInfo
15 Feb 2019:
How Eurostars-Eureka contributes to our mission to help individuals with spinal cord injury walk again : Patient with broken spine walks again
20 Dec 2018:
Interview in Dutch with Sjaak Deckers, CEO of GTX medical: High Tech Campus podcast
31 Oct 2018:
EPFL Press release:Breakthrough neurotechnology for treating paralysis